Literature DB >> 25163313

[Diagnosis of thrombosis by hemostatic markers].

Hideo Wada, Takeshi Matsumoto, Yoshiki Yamashita.   

Abstract

Hemostatic markers are measured when diagnosing cases presenting with either thrombosis or thrombophilia. Decreased antithrombin (AT), protein C and protein S levels, and positive anti-phospholipid antibody findings together suggest a risk for venous thromboembolism (VTE). Increased thrombin AT complex (TAT) and soluble fibrin (SF) levels indicate a hypercoagulable state, and the addition of elevated fibrinogen and fibrin degradation products (FDP) as well as D-dimer suggests the presence of VTE. D-dimer is frequently measured in VTE cases, but this marker is affected by fibrinolysis and requires standardization. The prothrombin time, FDP and fibrinogen are all used in the diagnosis of disseminated intravascular coagulation. Markedly reduced ADAMTS13 level is a useful sign for the diagnosis of thrombotic thrombocytopenic purpura.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25163313

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

1.  Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis.

Authors:  Xiao Fu; Jian-Ping Ning
Journal:  J Mater Sci Mater Med       Date:  2018-05-09       Impact factor: 3.896

2.  Prevalence and Characteristics of Hepatic Hemangioma Associated with Coagulopathy and Its Predictive Risk Factors.

Authors:  Shigeo Maruyama; Tomomitsu Matono; Masahiko Koda
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.